I have found the ZOE podcast interesting (no financial involvement) And Margaret MCartnetny view in the BMJ see also Weight Loss in Lactation | InfantRisk Center July 2025 please be aware of the risk of pancreatitis GLP-1 receptor agonists: MHRA to study possible side effects after acute pancreatitis cases | The BMJThe BMJ Data from the Medicines and Healthcare Products Regulatory Agency (MHRA) show that hundreds of cases of acute and chronic pancreatitis, including 10 deaths, have been reported in people taking the drugs, which are used to treat weight loss and diabetes by mimicking a natural hormone released after eating, although it is not certain that the drugs are the cause. June 2025 the MHRA recommended that all women taking skinny jabs should use effective contraception
You deserve more than drop some pounds and stop the drug. You deserve a healed system one that sustains energy, confidence, and vitality long after the prescription ends
Absorption Considerations : A systematic review in the Clinical Endocrinology journal (2019) highlighted the impact of dietary and pharmacological factors on levothyroxine absorption, critical for medication timing and efficacy
Expanding cardiovascular indications for semaglutide: results from the SOUL and STRIDE trials
Usage peaks among those ages 50-64, then drops sharply after 65likely because Medicare doesnt cover GLP-1s prescribed solely for weight loss
(PubMed) Clark LC, Combs GF, Jr., Turnbull BW, et al